Bartlett & Co. LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Bartlett & Co. LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$156
-30.0%
37,0370.0%0.00%
-25.0%
Q4 2022$223
-99.9%
37,0370.0%0.00%
-20.0%
Q3 2022$216,000
+27.1%
37,037
+1.5%
0.01%
+66.7%
Q1 2022$170,000
+86.8%
36,5000.0%0.00%
+50.0%
Q4 2021$91,000–36,500–0.00%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders